The CXCR3(+)CD56Bright Phenotype Characterizes a Distinct NK Cell Subset with Anti-Fibrotic Potential That Shows Dys-Regulated Activity in Hepatitis C

Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice

(2011) Won-Il Jeong et al.   HEPATOLOGY

Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases

(2011) Frank Tacke et al.   LIVER INTERNATIONAL

Amelioration of hepatic fibrosis by NK cell activation

(2010) N. Muhanna et al.   GUT

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV

(2010) Armanda Casrouge et al.   JOURNAL OF CLINICAL INVESTIGATION

Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines

(2010) Damien Sène et al.   PLoS Pathogens

Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections

(2009) Barbara Oliviero et al.   GASTROENTEROLOGY

Peripheral CXCR3‐Associated Chemokines as Biomarkers of Fibrosis in Chronic Hepatitis C Virus Infection

(2009) Marija Zeremski et al.   JOURNAL OF INFECTIOUS DISEASES

Innate immunity and alcoholic liver fibrosis

(2008) Won-Il Jeong et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation

(2008) Stefania Varchetta et al.   JOURNAL OF HEPATOLOGY

Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis

(2007) Won–Il Jeong et al.   GASTROENTEROLOGY